Moderna Begins Testing Vaccine On Young Children, Infants

3
>>Follow Matzav On Whatsapp!<<

Moderna has begun testing its COVID-19 vaccine on children and infants between the ages of six months and 12 years old in a study, as the pharmaceutical company seeks to expand approval for its vaccine to children.

Moderna announced on Tuesday that the first participants in the KidCOVE study on pediatric COVID-19 vaccinations had been dosed. Moderna is the first of the companies with vaccines authorized in the U.S. to launch testing among infants.

The research expects to enroll 6,750 children older than six months and younger than 12 years old in the U.S. and Canada. The National Institute of Allergy and Infectious Diseases and the Biomedical Advanced Research and Development Authority will assist in the study.

The study will consist of two parts, with the first aiming to determine the correct dosage for efficacy for those between six months and 2 years old and, separately, for children between 2 years old and 12 years old.

Read more at The Hill.

{Matzav.com}


3 COMMENTS

  1. Is it fair that editors from Jewish media would not take the vaccine because they know the consequences of taking it as they are well informed of the truth from comments they must censor – under threat. Stop being cruel to your Jewish brethren and share what you know to save Jewish souls. כל המציל נפש אחת כאילו הציל עולם ומלואו

  2. Mind boggling.
    How can a normal parent allow experimentation on his/her child?
    How can it be legal?
    How is it not child abuse?

LEAVE A REPLY

Please enter your comment!
Please enter your name here